Answer
Whether aclidinium bromide or its metabolites pass into human milk is unknown; animal studies showed small amounts in milk, infant risk cannot be excluded, and deciding whether to stop breastfeeding or Eklira Genuair therapy requires weighing breastfeeding benefits for the child against treatment benefits for the woman.
Sources for this answer
- Eklira Genuair 322 micrograms inhalation powderZentiva · emc · SmPC §4.6 Fertility, pregnancy and lactation · Version 3Document updated
Sources checked